NASDAQ: ARBE
Arbe Robotics Ltd Stock

$1.82+0.11 (+6.43%)
Updated Dec 6, 2024
ARBE Price
$1.82
Fair Value Price
-$1.16
Market Cap
$147.34M
52 Week Low
$1.40
52 Week High
$2.57
P/E
-3.14x
P/B
8.56x
P/S
152.2x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.02M
Earnings
-$46.41M
Gross Margin
-75.3%
Operating Margin
-4,814.76%
Profit Margin
-4,567.9%
Debt to Equity
2.22
Operating Cash Flow
-$30M
Beta
0.45
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ARBE Overview

Arbe Robotics Ltd., a semiconductor company, provides 4D imaging radar solutions for automotive suppliers and manufacturers in Israel and the United States. It offers 4D imaging radar chipset solutions for autonomous driving, such as detecting stationary objects, identifying vulnerable road users, and eliminating false alarms without radar ambiguities. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ARBE's potential to beat the market

FStrong Sell
  • Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More

Zen Rating Component Grades

D
Value
C
Growth
C
Momentum
D
Sentiment
D
Safety
D
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Software Infrastructure

Industry Rating
A
ARBE
Ranked
#124 of 126

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$31.75A
$23.49A
$14.51A
View Top Software Infrastructure Stocks

Be the first to know about important ARBE news, forecast changes, insider trades & much more!

ARBE News

Overview

Due Diligence Score

–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARBE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ARBE ($1.82) is overvalued by 256.73% relative to our estimate of its Fair Value price of -$1.16 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ARBE ($1.82) is not significantly undervalued (256.73%) relative to our estimate of its Fair Value price of -$1.16 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ARBE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ARBE due diligence checks available for Premium users.

Valuation

ARBE fair value

Fair Value of ARBE stock based on Discounted Cash Flow (DCF)

Price
$1.82
Fair Value
-$1.16
Undervalued by
256.73%
ARBE ($1.82) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ARBE ($1.82) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ARBE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ARBE price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-3.14x
Industry
45.85x
Market
29.86x

ARBE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
8.56x
Industry
12.29x
ARBE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ARBE's financial health

Profit margin

Revenue
$123.0k
Net Income
-$12.6M
Profit Margin
-10,222.8%
ARBE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ARBE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$55.5M
Liabilities
$38.3M
Debt to equity
2.22
ARBE's short-term assets ($52.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARBE's short-term assets ($52.24M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARBE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.8M
Investing
$17.5M
Financing
$185.0k
ARBE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ARBE vs Software Infrastructure Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ARBEF$147.34M+6.43%-3.14x8.56x
PDYNC$134.30M-4.70%-2.06x5.73x
PAYSC$178.32M-1.19%22.20x6.26x
AILEF$184.94M+4.80%-0.42x63.27x
ALLTB$186.60M+0.21%-7.32x3.89x

Arbe Robotics Stock FAQ

What is Arbe Robotics's quote symbol?

(NASDAQ: ARBE) Arbe Robotics trades on the NASDAQ under the ticker symbol ARBE. Arbe Robotics stock quotes can also be displayed as NASDAQ: ARBE.

If you're new to stock investing, here's how to buy Arbe Robotics stock.

What is the 52 week high and low for Arbe Robotics (NASDAQ: ARBE)?

(NASDAQ: ARBE) Arbe Robotics's 52-week high was $2.57, and its 52-week low was $1.40. It is currently -29.18% from its 52-week high and 30.47% from its 52-week low.

How much is Arbe Robotics stock worth today?

(NASDAQ: ARBE) Arbe Robotics currently has 80,957,931 outstanding shares. With Arbe Robotics stock trading at $1.82 per share, the total value of Arbe Robotics stock (market capitalization) is $147.34M.

Arbe Robotics stock was originally listed at a price of $9.97 in Sep 9, 2020. If you had invested in Arbe Robotics stock at $9.97, your return over the last 4 years would have been -81.75%, for an annualized return of -34.64% (not including any dividends or dividend reinvestments).

How much is Arbe Robotics's stock price per share?

(NASDAQ: ARBE) Arbe Robotics stock price per share is $1.82 today (as of Dec 6, 2024).

What is Arbe Robotics's Market Cap?

(NASDAQ: ARBE) Arbe Robotics's market cap is $147.34M, as of Dec 9, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Arbe Robotics's market cap is calculated by multiplying ARBE's current stock price of $1.82 by ARBE's total outstanding shares of 80,957,931.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.